Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of fas expression in human esophageal cancer

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2057-2062

  Gratas, Catherine ^a   Tohma, Yasuo ^a   Barnas, Christoph ^a   Taniere, Philippe ^a   Hainaut, Pierre ^a   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032523931     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Berrino, F., Sant, M., Verdecchia, A., Capacaccia, R., Hakulinen, T., and Estève, J. Survival of Cancer Patients in Europe: the Eurocare Study. Lyon, France: IARC, 1995.
2. Muñoz, N., and Castellsague, X. Epidemiology of oesophageal cancer. Eur. J. Gastroenterol. Hepatol., 6: 649-655, 1994.
3. Montesano, R., Hollstein, M., and Hainaut, P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer, 69: 225-235, 1996.
4. Sarbia, M., Bittinger, F., Porschen, R., Verreet, P., Dutkowski, P., Willers, R., and Gabbert, H. E. bcl-2 expression and prognosis in squamous-cell carcinomas of the esophagus. Int. J. Cancer, 69: 324-328, 1996.
5. Ohbu, M., Saegusa, M., Kobayashi, N., Tsukamoto, H., Mieno, H., Kakita, A., and Okayasu, I. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer (Phila.), 79: 1287-1293, 1997.
6. Nagata, S. Apoptosis by death factor. Cell, 88: 355-365, 1997.
7. Nagata, S., and Golstein, P. The Fas death factor. Science (Washington DC), 267: 1449-1456, 1995.
8. Alderson, M. R., Tough, T. W., Davis Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., and Lynch, D. H. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med., 181: 71-77, 1995.
9. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell, 75: 1169-1178, 1993.
10. Hahne, M., Renno, T., Schroeter, M., Irmler, M., French, L., Bornard, T., MacDonald, H. R., and Tschopp, J. Activated B cells express functional Fas ligand. Eur. J. Immunol., 26: 721-724, 1996.
11. Loughran, T. P. J. Clonal diseases of large granular lymphocytes. Blood, 82: 1-14, 1993.
12. Leithauser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Bruderlein, S., Henne, C., Schmidt, A., Debatin, K. M., Krammer, P. H., and Moller, P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest., 69: 415-429, 1993.
13. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A., and Nagata, S. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J. Immunol., 148: 1274-1279, 1992.
14. French, L. E., Hahne, M., Viard, I., Radlgruber, G., Zanone, R., Becker, K., Muller, C., and Tschopp, J. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol., 133: 335-343, 1996.
15. Strand, S., Hofmann, W. J., Hug, H., Muller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., and Galle, P. R. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion? Nat. Med., 2: 1361-1366, 1996.
16. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J-C., and Tschopp, J. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science (Washington DC), 274: 1363-1366, 1996.
17. Niehans, G. A., Brunner, T., Frizelle, S. P., Liston, J. C., Salerno, C. T., Knapp, D. J., Green, D. R., and Kratzte, R. A. Human lung carcinomas express Fas ligand. Cancer Res., 57: 1007-1012, 1997.
18. Saas, P., Walker, P. R., Hahne, M., Quiquerez, A-L., Schnuriger, V., Perrin, G., French, L., Van Meir, E. G., de Tribolet, N., Tschopp, J., and Dietrich, P-Y. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest., 99: 1173-1178, 1997.
19. Gratas, C., Tohma, Y., Van Meir, E. G., Klein, M., Tenan, M., Ishii, N., Tachibana, O., Kleihues, P., and Ohgaki, H. Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol., 7: 863-869, 1997.
20. O'Connell, J., O'Sullivan, G. C., Collins, J. K., and Shanahan, F. The Fas-counter-attack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med., 184: 1075-1082, 1996.
21. Shiraki, K., Tsuji, N., Shioda, T., Isselbacher, K. J., and Takahashi, H. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc. Natl. Acad. Sci. USA, 94: 6420-6425, 1997.
22. Watanabe, H., Jass, J. R., and Sobin, L. H. Histological typing of oesophageal and gastric tumours. In: International Histological Classification of Tumours, Ed. 2. Berlin: Springer-Verlag, 1990.
23. Nishihira, T., Hashimoto, Y., Katayama, M., Mori, S., and Kuroki, T. Molecular and cellular features of esophageal cancer cells. J. Cancer Res. Clin. Oncol., 119: 441-449, 1993.
24. Barnas, C., Martel-Planche, G., Furukawa, Y., Hollstein, M., Montesano, R., and Hainaut, P. Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int. J. Cancer, 71: 1-9, 1997.
25. Tachibana, O., Nakazawa, H., Lampe, J., Watanabe, K., Kleihues, P., and Ohgaki, H. Expression of Fas/APO-1 during the progression of astrocytomas. Cancer Res., 55: 5528-5530, 1995.
26. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., and Mountz, J. D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science (Washington DC), 263: 1759-1762, 1994.
27. Knipping, E., Debatin, K. M., Stricker, K., Heilig, B., Eder, A., and Krammer, P. H. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood, 85: 1562-1569, 1995.
28. Wang, H. H., Mangano, M. M., and Antonioli, D. A. Evaluation of T-lymphocytes in esophageal mucosal biopsies. Mod. Pathol., 7: 55-58, 1994.
29. Sadanaga, N., Kuwano, H., Watanabe, M., Maekawa, S., Mori, M., and Sugimachi, K. Local immune response to tumor invasion in esophageal squamous cell carcinoma. The expression of human leukocyte antigen-DR and lymphocyte infiltration. Cancer (Phila.), 74: 586-591, 1994.
30. Cascino, I., Fiucci, G., Papoff, G., and Ruberti, G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol., 154: 2706-2713, 1995.
31. Natoli, G., Ianni, A., Costanzo, A., De Petrillo, G., Ilari, I., Chirillo, P., Balsano, C., and Levrero, M. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene, 11: 1157-1164, 1995.
32. Owen Schaub, L. B., Angelo, L. S., Radinsky, R., Ware, C. F., Gesner, T. G., and Bartos, D. P. Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis? Cancer Lett., 94: 1-8, 1995.
33. Midis, G. P., Shen, Y., and Owen Schaub, L. B. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res., 56: 3870-3874, 1996.
34. Papoff, G., Cascino, I., Eramo, A., Starace, G., Lynch, D. H., and Ruberti, G. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J. Immunol., 156: 4622-4630, 1996.
35. Ohbu, M., Saegusa, M., and Okayasu, I. Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas: differences between keratinizing and nonkeratinizing types. Virchows Arch., 427: 271-276, 1995.